Search results
Results from the WOW.Com Content Network
Methods of prevention include gradually decreasing the dose among those who wish to stop, though it is possible for symptoms to occur with tapering. [2] [6] [4] Treatment may include restarting the medication and slowly decreasing the dose. [2] People may also be switched to the long-acting antidepressant fluoxetine which can then be gradually ...
Desvenlafaxine, sold under the brand name Pristiq among others, is a medication used to treat depression. [5] It is an antidepressant of the serotonin-norepinephrine reuptake inhibitor (SNRI) class and is taken by mouth. [5] It is recommended that the need for further treatment be occasionally reassessed. [5]
The list is ordered alphabetically according to the condition or conditions, then by the generic name of each medication. The list is not exhaustive and not all drugs are used regularly in all countries. Some medications treat multiple conditions and appear multiple times.
The analysis also found that severe discontinuation symptoms, which might cause patients to drop out of a study or resume taking antidepressants, occurred in about 3% — or one in 35 — of those ...
Nearly 30 percent of adults will deal with an anxiety disorder at some point in their lives, according to the American Psychiatric Association. If that's you, the medication Lexapro may come up if ...
However, the starting dose must be lower than the one used for major depressive disorder because people have reported an increase in anxiety as a result of starting the medication. In conclusion, while panic disorder's treatment options seem acceptable and useful for this condition, many people are still symptomatic after treatment with ...
According to the FDA, the medication had the "presence" of an impurity – a potentially cancer-causing substance, or nitrosamine – called N-nitrosoduloxetine, that exceeds the recommended limit.
SSRIs and SNRIs have been shown to be effective in treating major depressive disorder and anxiety in pediatric populations. [94] However, differences in metabolism, renal function, and total percentage of body water and body fat can influence the pharmacokinetics of medications in youths as compared to adults. [ 95 ]